Hyaluronic acid-enriched bilosomes: an approach to enhance ocular delivery of agomelatine via D-optimal design: formulation, in vitro characterization, and in vivo pharmacodynamic evaluation in rabbits
Agomelatine (AGO) is a dual-functional drug. It uses as an antidepressant when orally administrated and antiglaucomic when topically applied to the eye. This study aimed to formulate AGO into bilosomal vesicles for glaucoma treatment, as modern studies pointed out the effect of topical AGO on intrao...
Main Authors: | Asmaa Ashraf Nemr, Galal Mohamed El-Mahrouk, Hany Abdo Badie |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2022-12-01
|
Series: | Drug Delivery |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/10717544.2022.2100513 |
Similar Items
-
Hyaluronic acid-functionalized bilosomes for targeted delivery of tripterine to inflamed area with enhancive therapy on arthritis
by: Hailing Yang, et al.
Published: (2019-01-01) -
Acute angle closure glaucoma induced by selective serotonin reuptake inhibitor, and reversed by agomelatine
by: Mehmet Emin Demirkol, et al.
Published: (2019-12-01) -
Bilosomes as a promising nanoplatform for oral delivery of an alkaloid nutraceutical: improved pharmacokinetic profile and snowballed hypoglycemic effect in diabetic rats
by: Mohammed H. Elkomy, et al.
Published: (2022-12-01) -
Evaluation of Metformin Hydrochloride Tailoring Bilosomes as an Effective Transdermal Nanocarrier
by: Salem HF, et al.
Published: (2022-03-01) -
Agomelatine – pharmacological properties and use in psychiatric practice
by: Marcin Siwek, et al.
Published: (2019-06-01)